Leadership & Company

Meet the Team Behind eyentelligence

Born from applied research at Harvard Extension School and developed through the Harvard Innovation Lab — building intelligent systems from research to production.

Harvard Extension School
|
Harvard Innovation Lab — Member Project
|
NVIDIA Inception
David Walker

David Walker

Founder & CEO

David Walker is the Founder & CEO of eyentelligence, an AI innovation company that grew out of applied research conducted during his studies at Harvard Extension School. The venture is a member project of the Harvard Innovation Lab and a member of the NVIDIA Inception Program for AI-focused startups.

With expertise in AI/ML engineering and a background in healthcare technology, David leads eyentelligence's mission to build transparent, ethical, and production-ready intelligent systems. His academic research spans emotional AI, GPU-accelerated computational biology, and AI safety — translating interdisciplinary study into real-world applications.

Under his leadership, eyentelligence has developed six active projects including real-time emotion detection, cancer-immune cell simulation, independent AI safety testing, and autonomous multi-agent software factories.

About eyentelligence

Founded

2025

Headquarters

Flower Mound, TX

Entity

Texas LLC

Origins

Harvard Extension

Emotional AI

Privacy-first emotion detection with multi-modal analysis

Computational Biology

GPU-accelerated digital twin platform for precision cancer medicine

AI Safety & Ethics

Independent AI testing and worker empowerment platform

Autonomous Agents

Multi-agent pipelines for marketing and software development

Company Timeline

2025

Academic Origins

Began as applied research during degree studies at Harvard Extension School

2025

Harvard Innovation Lab

Accepted as a member project of the Harvard Innovation Lab

2025

NVIDIA Inception

Accepted into the NVIDIA Inception Program for AI startups

2025

Incorporated

Established as a Texas LLC, currently converting to Delaware corporation

2026

6 Active Projects

Research-to-production pipeline spanning AI safety, biology, and autonomous agents